SK

Suresh Keshav Bowalekar

Director Director DIN 00311661
DIN 00311661 First appointment Nov 2003 Primary industry General Business
Unlock full profile Investments Β· shareholding Β· contact details
Current companies –
Past companies 1 historical roles
Total affiliations 1 Since Nov 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Suresh Keshav Bowalekar

Data last updated:

Suresh Keshav Bowalekar has 22 years in corporate governance. Formerly with 1 company, such as Pharmanet Clinical Services Private Limited. Engaged in General Business. Contributes to corporate operations.

DIN 00311661
Primary Designation Director
First Appointment 07 Nov 2003
Oldest Company Age –

Current companies

No current companies available.

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director07 Nov 20032002–Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Pharmanet Clinical Services Private Limited
Premium access

Shareholding and investment profile for Suresh Keshav Bowalekar

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suresh Keshav Bowalekar

Suresh Keshav Bowalekar has 22 years in corporate governance. Formerly with 1 company, such as Pharmanet Clinical Services Private Limited. Engaged in General Business. Contributes to corporate operations.

Suresh Keshav Bowalekar has expertise in General Business.

Suresh Keshav Bowalekar has 22 years in corporate governance.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available